The Cancer Letter

Inside information on cancer research and drug development

NCI Director's Report

Biden’s budget request for NCI would set back Sharpless’s goal of raising R01 paylines to 15%

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
BYLINE
IN THIS ISSUE
BYLINEDOWNLOAD PDFTABLE OF CONTENTS

True, President Joe Biden is proposing the largest-ever funding increase for NIH, with a substantial percentage of funds going toward cancer (The Cancer Letter, April 9, May 28, June 4, 2021).

Alas, cancer researchers who have been funded by NCI are unlikely to benefit from this windfall, should it materialize. Most of the new money—$6.5 billion—would go to the Advanced Research Projects Agency for Health, or ARPA-H, and NCI is slated to get a less-than-jaw-dropping 2.7% increase in fiscal 2022.

While 2.7% is not nothing, it will do very little to enable NCI in its efforts to wrestle the Research Project Grants payline up to the 15th percentile by 2025 (The Cancer Letter, Feb. 12, 2021). In February, NCI Director Ned Sharpless said NCI was on track to meet that goal In FY2021, but this may be knocked off track—and off the rails.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Byline
Alexandria Carolan
Alexandria Carolan
Reporter
Table of Contents

YOU MAY BE INTERESTED IN

NCI Director's Report

As NCI’s appropriations stay flat, Rathmell keeps the FY26 bypass budget steady at just under $11.5B
Rathmell: “We understand that there are real economic constraints facing our country and the world. But our gap just can’t keep widening.”

NCI Director Kimryn Rathmell has released her professional judgment budget proposal, requesting nearly $11.5 billion—the same amount as last year’s proposal prepared by her predecessor, Monica Bertagnolli.
By Jacquelyn Cobb
In Brief

NCI funds a $3.7M effort to develop AI that predicts breast cancer risk while addressing health disparities

Researchers at Indiana University School of Medicine, Mayo Clinic, Washington University in St. Louis, the University of Pennsylvania, Columbia University, and Intel received a five-year, $3.7 million NCI grant for a multi-site study developing a privacy-preserving artificial intelligence approach—called federated learning—which aims to improve breast cancer risk prediction and reduce health inequities in cancer prevention care. 
Byline
Alexandria Carolan
Alexandria Carolan
Reporter
Table of Contents

Can you spare 10 minutes to complete a survey?

Your feedback is really important—you're helping us shape our coverage priorities and services to better serve you, our readers.
COMPLETE OUR SURVEY

Login

Site license subscribers:
Log in with your IP | Register a sponsored account